Streamex Corp. Form 8-K Summary
Business Context and Reporting Period
Streamex Corp. (formerly BioSig Technologies, Inc.), a Delaware corporation, filed this Current Report on Form 8-K on October 30, 2025. The company is headquartered in Winter Park, Florida, and its common stock trades on The Nasdaq Capital Market under the ticker symbol "STEX."
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Corporate Events
- Nasdaq Listing Approval: Nasdaq granted formal approval for the continued listing of Streamex Corp.'s common stock on The Nasdaq Capital Market.
- Special Stockholder Meeting: The company announced a reconvened special meeting of stockholders scheduled for November 4, 2025, at 3:00 p.m. Eastern Time.
- Meeting Purpose: The meeting will address Proposal 1, the Acquisition Proposal, which was previously adjourned, for a formal vote and approval.
- Meeting Format: The meeting will be conducted via webcast at www.virtualshareholdermeeting.com/BSGM2025SM.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the context of the pending acquisition vote. The information is furnished under Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the outcome of the Acquisition Proposal at the special meeting on November 4, 2025.
- Confirm the continued listing status of "STEX" on The Nasdaq Capital Market following the formal approval.
- Review the full text of the press release (Exhibit 99.1) for details on the acquisition terms not included in this summary.
- Check for subsequent filings regarding the results of the stockholder vote.